Oxford Asset Management’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-74,202
Closed -$1.76M 741
2025
Q1
$1.76M Buy
+74,202
New +$1.76M 0.81% 15
2020
Q1
Sell
-94,272
Closed -$1.48M 1116
2019
Q4
$1.48M Buy
+94,272
New +$1.07M 0.04% 610
2017
Q3
Sell
-14,291
Closed -$325K 1681
2017
Q2
$325K Buy
+14,291
New +$294K 0.01% 1243
2017
Q1
Sell
-71,632
Closed -$1.14M 1469
2016
Q4
$1.14M Sell
71,632
-24,978
-26% -$415K 0.04% 446
2016
Q3
$1.96M Sell
96,610
-69,345
-42% -$1.27M 0.06% 410
2016
Q2
$2.97M Buy
165,955
+67,285
+68% +$1M 0.1% 273
2016
Q1
$1.31M Sell
98,670
-51,465
-34% -$796K 0.04% 453
2015
Q4
$3.18M Buy
+150,135
New +$2.87M 0.07% 292

Other funds holding SGRY

Oxford Asset Management's SGRY Position: Q2 2025 in Review

Oxford Asset Management sold out of Surgery Partners (SGRY) in Q2 2025, closing a stake of 74,202 shares — an estimated $1.76M sold.

Oxford Asset Management first reported a position in SGRY in Q4 2015 and held it in 8 quarters. The position peaked at $3.18M in Q4 2015. 201 funds tracked by Wall St. Rank hold SGRY as of Q2 2025.

  • Oxford Asset Management reported no remaining Surgery Partners position as of Q2 2025 after selling out during the quarter.
  • Oxford Asset Management sold 74,202 Surgery Partners shares in Q2 2025, an estimated $1.76M.
  • Oxford Asset Management first reported a position in Surgery Partners in Q4 2015 and held it in 8 quarters.
  • Oxford Asset Management's Surgery Partners position peaked at $3.18M in Q4 2015.
  • 201 funds tracked by Wall St. Rank held Surgery Partners as of Q2 2025.

Based on Oxford Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.